Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952063 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Elongation Factor RNA Polymerase II (ELL) (AA 523-553), (C-Term) antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- C-Term, AA 523-553
- Vial size
- mL followed by peptide affinity purification.\"\"\"
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.
Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Liu L, Ai J, Xiao W, Liu J, Wang Y, Xin D, He Z, Guo Y, Wang Z
The Prostate 2010 May 15;70(7):797-805
The Prostate 2010 May 15;70(7):797-805
Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.
Zhou J, Feng X, Ban B, Liu J, Wang Z, Xiao W
The Journal of biological chemistry 2009 Jul 10;284(28):19142-52
The Journal of biological chemistry 2009 Jul 10;284(28):19142-52
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ
Science (New York, N.Y.) 2007 May 25;316(5828):1160-6
Science (New York, N.Y.) 2007 May 25;316(5828):1160-6
FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Jiang F, Ai J, Xiao W, Wang Z
Cancer letters 2007 Aug 18;253(2):265-72
Cancer letters 2007 Aug 18;253(2):265-72
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
